Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04308863
Other study ID # Chitosan vs MTA
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date November 15, 2018
Est. completion date December 20, 2020

Study information

Verified date May 2022
Source University of Alexandria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the clinical and radiographic outcomes of Chitosan scaffold and Mineral trioxide aggregate (MTA) when used as pulpotomy agents in mature permanent teeth with irreversible pulpitis.


Description:

Thirty permanent mandibular molars of patients with signs and symptoms of irreversible pulpitis will be selected. They will be randomly allocated into two groups, Group 1(Chitosan scaffold/ MTA pulp dressing materials), Group 2 (MTA pulp dressing material). A single visit full pulpotomy procedure will be carried out. Chitosan scaffold and / or MTA will be used as the pulp dressing materials. The teeth will be then restored with base of Glass ionomer cement followed by composite restoration.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 20, 2020
Est. primary completion date October 30, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Participants free from any systemic disease. - Deep caries in a permanent lower molar with mature roots. - Probing pocket depth and mobility within normal limits. - No signs of pulpal necrosis including sinus tract or swelling. - Vital bleeding pulp tissue should be present in all canals after complete pulpotomy. - The tooth is restorable. - Clinical diagnosis of symptomatic irreversible pulpitis based on subjective and objective examinations: - Subjective examination: Patients complaining of intermittent or spontaneous pain or pain exacerbated by dramatic temperature changes especially to cold stimuli and lasting for a few seconds to several hours. - Objective examination: - Clinical examination: Teeth that will experience immediate, excruciatingly painful sensation as soon as the cold stimulus is placed on and which may last for a while even after the removal of the stimulus. - Radiographic examination: Preoperative radiographs will be taken using a paralleling device. - The periapical index developed by Orstavik et al. (1986)(35) will be used to score cases with periapical rarefaction during diagnosis and follow-up periods. It consists of five categories: 1. Normal periapical structures. 2. Small changes in bone structures. 3. Change in bone structure with mineral loss. 4. Periodontitis with well-defined radiolucent area. 5. Severe periodontitis with exacerbating features. Score 1 and 2 are considered healthy, score 3-5 are considered diseased - The teeth that will be included should have score 1 or 2. Exclusion Criteria: - Negative response to cold testing. - No pulp exposure after caries excavation. - Bleeding could not be controlled in 10 minutes after 2.5% NaOCl - Absence of bleeding from any of the canals. - Teeth with radiographic signs of internal resorption. - Pulpal calcifications. - Participants with stainless-steel wires and brackets.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Chitosan scaffold/ MTA pulp dressing material
Chitosan 3-D porous scaffold will be prepared. The chitosan scaffolds will be examined with the Scanning electron microscopy (SEM) to analyze the surface of the chitosan scaffolds. The scaffolds will be sterilized by Ethylene oxide and stored until further use. A piece of 2-mm thick chitosan scaffold will be gently placed onto the pulp chamber floor and covering the canal orifices, and then a 2-3 mm thick layer of fast setting EndoCem Zr MTA will be applied onto the chitosan scaffold and will be gently condensed with moistened cotton pellet to attain adequate thickness which will be confirmed radiographically. MTA will be allowed to set for 4-5 mins.
MTA pulp dressing material
MTA will be gently placed over the fresh pulp wound using an MTA carrier to a thickness of 2-3 mm. It will be condensed lightly with moistened cotton pellet to attain adequate thickness and confirmed radiographically. MTA will be allowed to set for 4-5 mins.

Locations

Country Name City State
Egypt Faculty of Dentistry, Alexandria University Alexandria

Sponsors (2)

Lead Sponsor Collaborator
Nourhan M.Aly Alexandria University

Country where clinical trial is conducted

Egypt, 

References & Publications (5)

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. — View Citation

Ho MH, Kuo PY, Hsieh HJ, Hsien TY, Hou LT, Lai JY, Wang DM. Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. Biomaterials. 2004 Jan;25(1):129-38. — View Citation

Kumar V, Juneja R, Duhan J, Sangwan P, Tewari S. Comparative evaluation of platelet-rich fibrin, mineral trioxide aggregate, and calcium hydroxide as pulpotomy agents in permanent molars with irreversible pulpitis: A randomized controlled trial. Contemp Clin Dent. 2016 Oct-Dec;7(4):512-518. — View Citation

Li F, Liu X, Zhao S, Wu H, Xu HH. Porous chitosan bilayer membrane containing TGF-ß1 loaded microspheres for pulp capping and reparative dentin formation in a dog model. Dent Mater. 2014 Feb;30(2):172-81. doi: 10.1016/j.dental.2013.11.005. Epub 2013 Dec 12. — View Citation

Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action. J Endod. 2010 Mar;36(3):400-13. doi: 10.1016/j.joen.2009.09.009. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Assessment Postoperative pain will be recorded on Numerical Rating Pain Scale (NRS) that will be given to the patient to record his pain intensity in the range between 0-10, until the seventh day after treatment. Pain on the NRS will be further categorized as: No pain (0), Mild (1-3), Moderate (4-6), and Severe (7-10) pain. one week
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization baseline
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization 1 month
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization 3 months
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization 6 months
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization 9 months
Primary Mineralization Activity Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization 12 months
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration baseline
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration 1 month
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration 3 months
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration 6 months
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration 9 months
Primary Root Canal Obliteration Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration 12 months
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption baseline
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption 1 month
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption 3 months
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption 6 months
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption 9 months
Primary Internal Root Resorption Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption 12 months
Secondary Changes in the dental pulp in treated teeth This will be performed in comparison to a non-affected tooth with clinical vitality and without any additional past treatment. All observers will analyze the images using the following rating scale regarding to alterations of signal intensity of the dental pulp at nT1w, fsT1w, and fsT2w at distinct time intervals (1 = no signs of alterations of signal intensity of the dental pulp between affected and non-affected teeth, 2 = slightly alterations of signal intensity of the dental pulp between affected and nonaffected teeth, and 3 = obvious alterations of signal intensity of the dental pulp between affected and nonaffected teeth) 6 months
Secondary Peri-radicular/furcal pathosis Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of any peri-radicular/furcal pathosis 12 months
Secondary Internal and external root resorption Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of internal or external root resorption 12 months
See also
  Status Clinical Trial Phase
Completed NCT06268912 - Cryoanalgesia for Irreversible Pulpitis N/A
Completed NCT06330519 - Impact of Different Techniques on The Efficacy of Anaesthesia in Mandibular Molars With Acute Irreversible Pulpitis Phase 4
Recruiting NCT05336682 - Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp N/A
Recruiting NCT03956199 - Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis N/A
Completed NCT03174860 - Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success Phase 2/Phase 3
Completed NCT05853185 - Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy. Phase 4
Not yet recruiting NCT03612323 - Comparison Between Intraligamentary Piroxicam and Articaine Early Phase 1
Not yet recruiting NCT02953912 - Assessment of Postoperative Pain Using Reciproc Versus One Shape Files in Patients With Irreversible Pulpitis N/A
Completed NCT04719247 - Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth N/A
Completed NCT05582317 - Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars N/A
Recruiting NCT05402098 - Outcome Following Endodontic Treatment Using Traditional Access Versus Conservative Access N/A
Recruiting NCT05406557 - Partial Versus Miniature Pulpotomy in Teeth With Irreversible Pulpitis N/A
Recruiting NCT05902936 - Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments N/A
Recruiting NCT03553407 - Analgesic Effect of Low Intensity Laser in Patients With Pulpitis of Mandibular Molars. N/A
Completed NCT05904184 - Comparison of Calcium Silicate-based Sealer and Epoxy Resin-based Sealer Phase 3
Not yet recruiting NCT03916900 - Postoperative Pain and Success Rate in Pulpotomy Versus Root Canal Treatment N/A
Completed NCT06088446 - Effect of Intrapulpal Injections on the Post-endodontic Pain N/A
Enrolling by invitation NCT05964933 - Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis N/A
Withdrawn NCT04996641 - Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer Patients N/A
Not yet recruiting NCT02952300 - Post Operative Pain of Root Canal Preparation With Wave One and Neolix in Acute Irreversible Pulpitis N/A